Cardio Diagnostics Holdings Stock Investor Sentiment

CDIOW Stock  USD 0.03  0.01  23.08%   
Slightly above 59% of Cardio Diagnostics' investor base is looking to short. The analysis of the overall investor sentiment regarding Cardio Diagnostics Holdings suggests that many traders are alarmed. Cardio Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Cardio Diagnostics' earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
Torray Investment Partners LLC Grows Stock Holdings in Lantheus ... - MarketBeat
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Cardio Diagnostics Holdings, Inc. Sees Significant Increase in Short Interest
news
over a year ago at news.google.com         
Mesirow Institutional Investment Management Inc. Has 12.52 ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Whats in Store for Abbott Laboratories in Q2 Earnings - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Analysis of Half a Billion Lipid Tests from Five Continents Reveals Wide Variation of Lipid-Associat...
Google News at Macroaxis
over a year ago at news.google.com         
If You Invested 1000 in HCA Healthcare a Decade Ago, This is ... - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Top 10 Medical Device Technologies Market is Expected to Reach ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Valideas Top 5 Health Care Stocks Based On Joel Greenblatt - 73 ... - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Biotricity Reports Business Update, Financial Results for Q4 and Full ... - BioSpace
Google News at Macroaxis
over a year ago at news.google.com         
Medical Device Outsourcing Market Excellent Growth Scope ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiova...
Google News at Macroaxis
over a year ago at news.google.com         
Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023 - ...
Google News at Macroaxis
over a year ago at news.google.com         
Enzyme Contract Manufacturing Global Market to Propel ... - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Cardiovascular Diagnostic Monitoring Devices Market to Cross US 29.0 Bn Mark by 2031, Says TMR Study...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Cardio Diagnostics that are available to investors today. That information is available publicly through Cardio media outlets and privately through word of mouth or via Cardio internal channels. However, regardless of the origin, that massive amount of Cardio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cardio Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardio Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardio Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardio Diagnostics alpha.

Cardio Diagnostics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Philibert Robert of 16000 shares of Cardio Diagnostics at 0.6 subject to Rule 16b-3
09/06/2024
2
Potential Catalyst Right Around The Corner CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics Heart Disease Tests - Yahoo Finance
09/17/2024
3
Cardio Diagnostics Holdings, Inc. Sees Large Increase in Short Interest
10/30/2024
4
Disposition of tradable shares by Levy Oded of Cardio Diagnostics subject to Rule 16b-3
11/01/2024
5
Cardio Diagnostics shareholders approve key proposals - Investing.com
11/18/2024

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.